New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai

被引:4
|
作者
Xie Guogang [1 ]
Zhang Yingying [1 ]
Zhou Xin [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Resp Med, Shanghai 200080, Peoples R China
关键词
chronic obstructive pulmonary disease; Global Initiative for Chronic Obstructive Lung Disease; chronic obstructive pulmonary disease assessment test; exacerbation; lung function test; HEALTH-STATUS; LUNG-FUNCTION; COPD; EXACERBATION; PREDICTION; PROPIONATE; DECLINE; COHORT;
D O I
10.3760/cma.j.issn.0366-6999.20141206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Global Initiative for Chronic Obstructive Lung Disease (GOLD) presented a new ABCD group classification of chronic obstructive pulmonary disease (COPD). We aimed to examine the association of spirometric classification and the new GOLD classification with exacerbations, and to compare symptoms in different ways. Methods We investigated 848 patients with stable COPD from 24 hospitals. The annual frequencies of acute exacerbation and hospitalization were compared between the old and new classification. The symptom level was assessed using COPD assessment test (CAT) and modified British Medical Research Council (mMRC) questionnaire. Results A total of 848 patients were included in this study. According to spirometric classification, there were 32 patients of grade I (3.8%), 315 of grade II (37.1%), 366 of grade III (43.2%), and 135 of grade IV (15.9%). According to GOLD 2011 classification, there were 59 patients of group A (7.0%), 172 of group B (20.3%), 55 of group C (6.5%), and 562 of group D (66.3%). In spirometric classification, the annual frequencies of acute exacerbation and associated hospitalization were respectively 1 (0-3) and 0 (0-2) for grade I; 1 (0-5) and 0 (0-2) for grade II; 2 (0-6) and 1 (0-3) for grade III, and 3 (0-6) and 2 (0-3) for grade IV. In GOLD 2011, respectively 0 (0-3) and 0 (0-1) (group A), 1 (0-4) and 0 (0-3) (group B), 1 (0-5) and 0 (0-3) (group C), and 3 (0-6) and 1 (0-3) (group D). There were no significant difference between group B and C (Z=similar to 1.347, P=0.178; Z= -0.772, P=0.440, respectively). The coincidence rate using mMRC=1 and CAT=10 as cutoff points was 86.6% (734/848, kappa=0.706), compared with 77.9% (661/848, kappa=0.60) using mMRC=2 and CAT=10. Conclusions Lung function test may be a better predictor of acute exacerbation and associated hospitalization of COPD. It is more appropriate to use mMRC=1 as cutoff point for assessing COPD symptoms.
引用
收藏
页码:3046 / 3050
页数:5
相关论文
共 50 条
  • [21] The Severity Of Pulmonary Hypertension As A Prognostic Indicator In Patients With Chronic Obstructive Pulmonary Disease
    Roberts, S. C.
    Mojadidi, M. K.
    Zolty, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [22] Classification of Exacerbation Episodes in Chronic Obstructive Pulmonary Disease Patients
    Dias, A.
    Gorzelniak, L.
    Schultz, K.
    Wittmann, M.
    Rudnik, J.
    Joerres, R.
    Horsch, A.
    METHODS OF INFORMATION IN MEDICINE, 2014, 53 (02) : 108 - 114
  • [23] ECHOCARDIOGRAPHIC EVALUATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AND ITS RELATION WITH THE SEVERITY OF DISEASE
    Kaur, Sukhdeep
    Khurana, Ashok
    Dhoat, Preeti Singh
    Mohan, Gurinder
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (101): : 7405 - 7408
  • [24] Treatment of stable chronic obstructive pulmonary disease
    Rennard, SI
    LANCET, 2004, 364 (9436): : 791 - 802
  • [25] Epicardial fat thickness is associated with severity of disease in patients with chronic obstructive pulmonary disease
    Kiraz, K.
    Gokdeniz, T.
    Kalaycioglu, E.
    Borekci, A.
    Akyol, S.
    Baykan, A. O.
    Acele, A.
    Karakoyun, S.
    Seker, T.
    Gur, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (21) : 4508 - 4515
  • [26] Pharmacotherapy in Stable Chronic Obstructive Pulmonary Disease
    Kim, Young Kyoon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (04): : 333 - 341
  • [27] Relationship between disease severity and quality of life in patients with chronic obstructive pulmonary disease
    Sanchez, F. F.
    Faganello, M. M.
    Tanni, S. E.
    Lucheta, P. A.
    Padovani, C. R.
    Godoy, I.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2008, 41 (10) : 860 - 865
  • [28] Management of Stable Chronic Obstructive Pulmonary Disease
    Fu, Danny
    Lapreze, Jennifer
    US PHARMACIST, 2013, 38 (07) : 43 - 46
  • [29] Correlation between body composition and disease severity in patients with chronic obstructive pulmonary disease
    Jin, Xiaohan
    Yang, Yu
    Chen, Guangmei
    Shao, Yue
    Liu, Chang
    Li, Rong
    Liu, Yazhuo
    Zhang, Lichuan
    FRONTIERS IN MEDICINE, 2024, 11
  • [30] Echocardiographic Evaluation of Patients with Chronic Obstructive Pulmonary Disease and Its Relation with the Severity of the Disease
    Rajput, Amardip
    Patil, Virendra C.
    Aundhakar, Swati C.
    Kulkarni, Chinmay
    Shetye, Jayesh S.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (04): : 446 - 452